MORGAN STANLEY - SINGULAR GENOMICS SYSTEMS IN ownership

SINGULAR GENOMICS SYSTEMS IN's ticker is OMIC and the CUSIP is 82933R100. A total of 49 filers reported holding SINGULAR GENOMICS SYSTEMS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of SINGULAR GENOMICS SYSTEMS IN
ValueSharesWeighting
Q3 2023$5,281
-90.3%
13,862
-78.8%
0.00%
Q2 2023$54,233
-47.2%
65,342
-23.1%
0.00%
Q1 2023$102,760
-53.1%
84,926
-22.0%
0.00%
Q4 2022$218,963
-14.5%
108,937
+6.5%
0.00%
Q3 2022$256,000
-18.7%
102,317
+24.0%
0.00%
Q2 2022$315,000
-3.4%
82,529
+60.1%
0.00%
Q1 2022$326,000
+72.5%
51,558
+214.5%
0.00%
Q4 2021$189,000
+204.8%
16,395
+194.2%
0.00%
Q3 2021$62,000
+6100.0%
5,573
+19117.2%
0.00%
Q2 2021$1,000290.00%
Other shareholders
SINGULAR GENOMICS SYSTEMS IN shareholders Q3 2023
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 9,112,019$250,398,0004.45%
Casdin Capital, LLC 2,692,870$74,000,0001.88%
Perceptive Advisors 6,165,740$169,434,0001.10%
Nicholas Investment Partners, LP 629,716$17,305,0001.08%
Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. 3,440$95,0000.71%
Orbimed Advisors 1,998,521$54,919,0000.56%
Alphabet Inc. 646,622$17,769,0000.36%
Pinz Capital Management, LP 36,400$1,000,0000.30%
NEXPOINT ASSET MANAGEMENT, L.P. 39,142$1,076,0000.24%
Coatue Management 2,119,614$58,247,0000.23%
View complete list of SINGULAR GENOMICS SYSTEMS IN shareholders